(S)-2-{[4-(2-methoxyethoxymethoxy)phenoxy]methyl}oxirane | 1160619-86-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (S)-2-{[4-(2-methoxyethoxymethoxy)phenoxy]methyl}oxirane
• 英文别名: (2S)-2-[[4-(2-methoxyethoxymethoxy)phenoxy]methyl]oxirane
• CAS: 1160619-86-2
• 化学式: C₁₃H₁₈O₅
• 分子量: 254.283
• InChiKey: SIVQVUDTUJUERT-CYBMUJFWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  18
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  49.4
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  、 (S)-2-{[4-(2-methoxyethoxymethoxy)phenoxy]methyl}oxirane 以 异丙醇 为溶剂， 反应 1.0h， 以32%的产率得到(S)-4'-[2-({2-hydroxy-3-[4-(2-methoxyethoxymethoxy)phenoxy]propyl}amino)ethyl]-2-(quinolin-2-yl)acetanilide
  参考文献：
  名称：

  Discovery of novel acetanilide derivatives as potent and selective β3-adrenergic receptor agonists

  摘要：

  In the search for potent and selective human beta 3-adrenergic receptor (AR) agonists as potential drugs for the treatment of obesity and noninsulin-dependent (type II) diabetes a novel series of acetanilide-based analogues were prepared and their biological activities were evaluated at the human beta 3-, beta 2-, and beta 1-ARs. Among these compounds, 2-pyridylacetanilide (2f), pyrimidin-2-ylacetanilide (2u), and pyrazin-2-ylacetanilide (2v) derivatives exhibited potent agonistic activity at the beta 3-AR with functional selectivity over the beta 1- and beta 2-ARs. In particular, compound 2u was found to be the most potent and selective beta 3-AR agonist with an EC(50) value of 0.11 mu M and no agonistic activity for either the beta 1 - or beta 2-AR. In addition, 2f, 2u, and 2v showed significant hypoglycemic activity in a rodent diabetic model. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2009.01.022
• 作为产物：
  描述：

  右旋环氧氯丙烷 、 4-(2-methoxyethoxymethoxy)phenol 在 氢氧化钾 作用下， 以 水 为溶剂， 反应 15.0h， 以58%的产率得到(S)-2-{[4-(2-methoxyethoxymethoxy)phenoxy]methyl}oxirane
  参考文献：
  名称：

  Discovery of novel acetanilide derivatives as potent and selective β3-adrenergic receptor agonists

  摘要：

  In the search for potent and selective human beta 3-adrenergic receptor (AR) agonists as potential drugs for the treatment of obesity and noninsulin-dependent (type II) diabetes a novel series of acetanilide-based analogues were prepared and their biological activities were evaluated at the human beta 3-, beta 2-, and beta 1-ARs. Among these compounds, 2-pyridylacetanilide (2f), pyrimidin-2-ylacetanilide (2u), and pyrazin-2-ylacetanilide (2v) derivatives exhibited potent agonistic activity at the beta 3-AR with functional selectivity over the beta 1- and beta 2-ARs. In particular, compound 2u was found to be the most potent and selective beta 3-AR agonist with an EC(50) value of 0.11 mu M and no agonistic activity for either the beta 1 - or beta 2-AR. In addition, 2f, 2u, and 2v showed significant hypoglycemic activity in a rodent diabetic model. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2009.01.022